Lupin and Mylan launch Nepexto, biosimilar etanercept in German market EP News Bureau Aug 26, 2020 Etanercept was first approved for the treatment of rheumatoid arthritis in Germany in 2000 and since then has offered an effective…
Lupin and Mylan receive European Marketing Authorization for Nepexto, Biosimilar Etanercept EP News Bureau Jun 4, 2020 A a phase 3 clinical study in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to…
